NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
U.S. House Republicans fail to impeach homeland security secretary over border security
Coronavirus: Documentary claims to expose Chinese COVID
Cruise expert gives his verdict on Icon of the Seas' most expensive restaurant
Body removed after violent attack at Auckland sushi shop
Alaska judge finds correspondence school reimbursements unconstitutional
Snake on a plane! Footage captures the moment a SERPENT emerges above an overhead bin mid
Peru protests block access to Machu Picchu, stranding tourists
Attacks on U.S. base resume in revenge campaign for Gaza: monitor
Changes to Gloriavale response could risk gains
Kowalczyk's first career goal sends Dynamo past Minnesota United 2
Why the Algarve has been named the top destination for a bargain break in Europe